Plain-English translation of NCT05450783 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing a new imaging technique called PET-MRI that combines two types of scanning to get a detailed look at the heart in people with arrhythmogenic cardiomyopathy, a genetic condition where the heart muscle weakens and can cause dangerous heart rhythms. This imaging tool has been used successfully in other heart conditions and may help doctors understand inflammation in the heart and predict how the disease will progress.
Currently, the only way to detect inflammation in the heart muscle is through a painful biopsy that takes a small tissue sample. This study aims to develop a non-invasive imaging method that can safely show what's happening inside the heart without surgery, which could help doctors better understand and treat the disease.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will undergo a PET-MRI scan, which is a combination imaging procedure that takes detailed pictures of your heart while you lie still in a scanner. The study is observational, meaning researchers will follow your progress over time and correlate the imaging findings with your symptoms and heart function, but you won't receive any experimental medication or invasive procedures as part of this trial.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
France